Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance

INTRODUCTION: Immune checkpoint inhibitors (ICIs) are widely used in the treatment of many cancers as they improve clinical outcomes. However, ICIs have also been associated with the development of immune-related adverse drug reactions (ADRs). Among immune-related ADRs, cardiac immune-related ADRs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mascolo, Annamaria, Scavone, Cristina, Ferrajolo, Carmen, Rafaniello, Concetta, Danesi, Romano, Del Re, Marzia, Russo, Antonio, Coscioni, Enrico, Rossi, Francesco, Alfano, Roberto, Capuano, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370948/
https://www.ncbi.nlm.nih.gov/pubmed/34145536
http://dx.doi.org/10.1007/s40264-021-01086-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370948/
https://www.ncbi.nlm.nih.gov/pubmed/34145536
http://dx.doi.org/10.1007/s40264-021-01086-8

Ejemplares similares